Concepedia

Ryan J. Holland

RJ

Statistics

Publications

14

Citations

437

H-Index

12

Active since

2010

Affiliations

National Cancer Institute(Current)

Frederick National Laboratory for Cancer Research

Science Applications International Corporation (United States)

Leidos (United States)

United States Naval Research Laboratory

Ryan J. Holland is an author at National Cancer Institute specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2010–2016

14

Publications

14

Synthesis and Chemical and Biological Comparison of Nitroxyl- and Nitric Oxide-Releasing Diazeniumdiolate-Based Aspirin Derivatives

Debashree Basudhar, Gaurav Bharadwaj, Robert Y.S. Cheng et al. · Journal of Medicinal Chemistry · 2013 · 77 citations · Full text

, , +13

The Nitric Oxide Prodrug JS-K Is Effective against Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen Species

Anna Maciąg, Harinath Chakrapani, Joseph E. Saavedra et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 68 citations · Full text

, , +11

Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance

Anna Maciąg, Ryan J. Holland, Y.-S. Robert Cheng et al. · Redox Biology · 2013 · 50 citations · Full text

, , +17

The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet

Edyta Maślak, Piotr Zabielski, Kamila Kochan et al. · Biochemical Pharmacology · 2014 · 42 citations · Full text

, , +14

Nitric Oxide (NO) Releasing Poly ADP-ribose Polymerase 1 (PARP-1) Inhibitors Targeted to Glutathione S-Transferase P1-Overexpressing Cancer Cells

Anna Maciąg, Ryan J. Holland, Youseung Kim et al. · Journal of Medicinal Chemistry · 2014 · 36 citations · Full text

, , +15

1–5 of 14